Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gregory

Showing results (291-300 of 322) with videos related to

Pageof 33
Sort By:
Blood|December 1, 2020
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomasScott Boiko, Theresa Proia, Maryann San Martin, et al.
Molecular Cancer Therapeutics|July 14, 2016
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family MembersSimon J Hogg, Andrea Newbold, Stephin J Vervoort, et al.
Frontiers in Genetics|August 11, 2015
Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancyAleeca F Bell, C S Carter, Colin D Steer, et al.
Blood Advances|March 22, 2023
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphomaMaciej Tatarczuch, Mark Waltham, Jake Shortt, et al.
BMC Health Services Research|May 3, 2008
Development and validation of the Diabetes Numeracy Test (DNT)Mary Margaret Huizinga, Tom A Elasy, Kenneth A Wallston, et al.
Journal of Colloid and Interface Science|December 26, 2022
From Hofmeister to hydrotrope: Effect of anion hydrocarbon chain length on a polymer brushHayden Robertson, Joshua D Willott, Kasimir P Gregory, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Haematologica|September 25, 2025
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry studyEliza Chung, Luke Wang, Cameron Wellard, et al.
Blood Advances|January 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature reviewLuke Wang, Eliza Chung, Cameron Wellard, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II TrialMatthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
Pageof 33

Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
Blood|December 1, 2020
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomasScott Boiko, Theresa Proia, Maryann San Martin, et al.
Molecular Cancer Therapeutics|July 14, 2016
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family MembersSimon J Hogg, Andrea Newbold, Stephin J Vervoort, et al.
Frontiers in Genetics|August 11, 2015
Interaction between oxytocin receptor DNA methylation and genotype is associated with risk of postpartum depression in women without depression in pregnancyAleeca F Bell, C S Carter, Colin D Steer, et al.
Blood Advances|March 22, 2023
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphomaMaciej Tatarczuch, Mark Waltham, Jake Shortt, et al.
BMC Health Services Research|May 3, 2008
Development and validation of the Diabetes Numeracy Test (DNT)Mary Margaret Huizinga, Tom A Elasy, Kenneth A Wallston, et al.
Journal of Colloid and Interface Science|December 26, 2022
From Hofmeister to hydrotrope: Effect of anion hydrocarbon chain length on a polymer brushHayden Robertson, Joshua D Willott, Kasimir P Gregory, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Haematologica|September 25, 2025
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry studyEliza Chung, Luke Wang, Cameron Wellard, et al.
Blood Advances|January 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature reviewLuke Wang, Eliza Chung, Cameron Wellard, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II TrialMatthew Matasar, Nancy L Bartlett, Mazyar Shadman, et al.
Pageof 33